The DOI matches its Crossref record; 633 of the 633 references it cites were found in a registry or an index.
Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders
Open accessAbstract
Autoimmune disorders are characterized by aberrant T cell and B cell reactivity to the body’s own components, resulting in tissue destruction and organ dysfunction. Autoimmune diseases affect a wide range of people in many parts of the world and have become one of the major concerns in public health. In recent years, there have been substantial progress in our understanding of the epidemiology, risk factors, pathogenesis and mechanisms of autoimmune diseases. Current approved therapeutic interventions for autoimmune diseases are mainly non-specific immunomodulators and may cause broad immunosuppression that leads to serious adverse effects. To overcome the limitations of immunosuppressive drugs in treating autoimmune diseases, precise and target-specific strategies are urgently needed. To date, significant advances have been made in our understanding of the mechanisms of immune tolerance, offering a new avenue for developing antigen-specific immunotherapies for autoimmune diseases. These antigen-specific approaches have shown great potential in various preclinical animal models and recently been evaluated in clinical trials. This review describes the common epidemiology, clinical manifestation and mechanisms of autoimmune diseases, with a focus on typical autoimmune diseases including multiple sclerosis, type 1 diabetes, rheumatoid arthritis, systemic lupus erythematosus, and sjögren’s syndrome. We discuss the current therapeutics developed in this field, highlight the recent advances in the use of nanomaterials and mRNA vaccine techniques to induce antigen-specific immune tolerance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 401–600 of 633
Delemarre, E. M., van den Broek, T., Mijnheer, G., Meerding, J., Wehrens, E. J., Olek, S., Boes, M. L., van Herwijnen, M. J. C., Broere, F., van Royen‐Kerkhof, A., et al. (2015) · Blood · doi:10.1182/blood-2015-06-649145 · Cited by 108
Gene therapy and type 1 diabetes mellitus
Chellappan, D. K., Sivam, N. S., Teoh, K. X., Leong, W. P., Fui, T. Z., Chooi, K., Khoo, N., Yi, F. J., Chellian, J., Cheng, L. L., et al. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.09.138 · Cited by 108
Umeshappa, C. S., Singha, S., Blanco, J., Shao, K., Nanjundappa, R. H., Yamanouchi, J., Parés, A. R., Serra, P., Yang, Y., & Santamaría, P. (2019) · Nature Communications · doi:10.1038/s41467-019-09893-5 · Cited by 108
Daikeler, T. D., Tichelli, A., & Passweg, J. R. (2012) · Pediatric Research · doi:10.1038/pr.2011.57 · Cited by 107
DNA Vaccines: History, Molecular Mechanisms and Future Perspectives
Pagliari, S., Dema, B., Sánchez-Martínez, A., Zurbia-Flores, G. M., & Rollier, C. S. (2023) · Journal of Molecular Biology · doi:10.1016/j.jmb.2023.168297 · Cited by 107
‘Passive’ nanoparticles for organ-selective systemic delivery: design, mechanism and perspective
Fu, L., Zhang, Y., Farokhzad, R. A., Mendes, B. B., Conde, J., & Shi, J. (2023) · Chemical Society Reviews · doi:10.1039/d2cs00998f · Cited by 106
Yachi, P. P., Ampudia, J., Żal, T., & Gascoigne, N. R. J. (2006) · Immunity · doi:10.1016/j.immuni.2006.05.015 · Cited by 105
SAR156597 in idiopathic pulmonary fibrosis: a phase 2 placebo-controlled study (DRI11772)
Raghu, G., Richeldi, L., Crestani, B., Wung, P. K., Bejuit, R., Espéret, C., Antoni, C., & Soubrane, C. (2018) · European Respiratory Journal · doi:10.1183/13993003.01130-2018 · Cited by 105
Tolerogenic Dendritic Cell-Based Approaches in Autoimmunity
Passeri, L., Fortunato, M., Bassi, V., & Gregori, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168415 · Cited by 105
Pathogenic cellular and molecular mediators in lupus nephritis
Mohan, C., Zhang, T., & Putterman, C. (2023) · Nature Reviews Nephrology · doi:10.1038/s41581-023-00722-z · Cited by 105
Nikolić, T., Zwaginga, J. J., Uitbeijerse, B. S., Woittiez, N. J. C., de Koning, E. J. P., Aanstoot, H., & Roep, B. O. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30104-2 · Cited by 104
Sharma, S., Nag, B., Su, X., Green, D. R., Spack, E. G., Clark, B. R., & Sriram, S. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.11465 · Cited by 103
Immunotherapy of autoimmune encephalomyelitis with redirected CD4+CD25+ T lymphocytes
Mekala, D. J., & Geiger, T. L. (2004) · Blood · doi:10.1182/blood-2004-09-3579 · Cited by 103
An antigen-encapsulating nanoparticle platform for TH1/17 immune tolerance therapy
McCarthy, D. P., Yap, J. W. T., Harp, C. T., Song, W. K., Chen, J., Pearson, R. M., Miller, S. D., & Shea, L. D. (2016) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2016.09.007 · Cited by 103
Use of Autoantigen-Loaded Phosphatidylserine-Liposomes to Arrest Autoimmunity in Type 1 Diabetes
Pujol‐Autonell, I., Prat, A. S., Cano‐Sarabia, M., Ampudia, R. M., Rodríguez-Fernández, S., Sánchez‐Pla, Á., Izquierdo, C., Stratmann, T., Puig‐Domingo, M., Maspoch, D., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127057 · Cited by 102
Factors affecting long-term efficacy of T regulatory cell-based therapy in type 1 diabetes
Marek-Trzonkowska, N. M., Myśliwiec, M., Iwaszkiewicz‐Grześ, D., Gliwiński, M., Derkowska, I., Żalińska, M., Zieliński, M., Grabowska, M., Zielińska, H., Piekarska, K., et al. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-1090-7 · Cited by 102
Karnell, J. L., Albulescu, M., Drabic, S. V., Wang, L., Moate, R., Baca, M., Oganesyan, V., Gunsior, M., Thisted, T., Li, Y., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aar6584 · Cited by 102
Self-citationHuibregtse, I. L., Marietta, E. V., Rashtak, S., Koning, F., Rottiers, P., David, C. S., van Deventer, S. J. H., & Murray, J. A. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802891 · Cited by 101
Nawaz, M., Heydarkhan‐Hagvall, S., Tangruksa, B., González‐King, H., Jing, Y., Maugeri, M., Kohl, F., Hultin, L., Reyahi, A., Camponeschi, A., et al. (2023) · Advanced Science · doi:10.1002/advs.202206187 · Cited by 100
Lewis, J. S., Dolgova, N. V., Zhang, Y., Xia, C. Q., Wasserfall, C. H., Atkinson, M. A., Clare-Salzler, M. J., & Keselowsky, B. G. (2015) · Clinical Immunology · doi:10.1016/j.clim.2015.03.023 · Cited by 99
Mansilla, M. J., Sellès‐Moreno, C., Fàbregas‐Puig, S., Amoedo, J., Navarro‐Barriuso, J., Teniente‐Serra, A., Grau‐López, L., Ramo-Tello, C. M., & Martínez-Cáceres, E. M. (2014) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12342 · Cited by 99
Gan, R. W., Demoruelle, M. K., Deane, K. D., Weisman, M. H., Buckner, J. H., Gregersen, P. K., Mikuls, T. R., O’Dell, J. R., Keating, R. M., Fingerlin, T. E., et al. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209154 · Cited by 99
Tsunawaki, S., Nakamura, S., Ohyama, Y., Sasaki, M., Ikebe‐Hiroki, A., Hiraki, A., Kadena, T., Kawamura, E., Kumamaru, W., Shinohara, M., et al. (2002) · PubMed · Cited by 99
Barbhaiya, M., Lü, B., Sparks, J. A., Malspeis, S., Chang, S., Karlson, E. W., & Costenbader, K. H. (2016) · Arthritis Care & Research · doi:10.1002/acr.22945 · Cited by 99
Multicomponent Injectable Hydrogels for Antigen‐Specific Tolerogenic Immune Modulation
Verbeke, C. S., Gordo, S., Schubert, D. A., Lewin, S. A., Desai, R. M., Dobbins, J., Wucherpfennig, K. W., & Mooney, D. J. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201600773 · Cited by 99
Wang, Z., Long, H., Chang, C., Zhao, M., & Lu, Q. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2864-2 · Cited by 99
Scott, I. C., Whittle, R., Bailey, J., Twohig, H., Hider, S., Mallen, C. D., Müller, S., & Jordan, K. P. (2022) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2022.100519 · Cited by 99
Spanier, J. A., Fung, V. C. W., Wardell, C. M., Alkhatib, M. H., Chen, Y., Swanson, L. A., Dwyer, A. J., Weno, M. E., Silva, N., Mitchell, J. S., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci168601 · Cited by 99
Effects of ATX-MS-1467 immunotherapy over 16 weeks in relapsing multiple sclerosis
Chataway, J., Martin, K. F., Barrell, K., Sharrack, B., Stolt, P., Wraith, D. C., For the ATX-MS1467 Study Group, ATX-MS1467 Study Group, Maslova, N. N., Fitilev, S. B., et al. (2018) · Neurology · doi:10.1212/wnl.0000000000005118 · Cited by 98
Molecular and functional analysis of monoclonal antibodies in support of biologics development
Wang, X., An, Z., Luo, W., Xia, N., & Zhao, Q. (2017) · Protein & Cell · doi:10.1007/s13238-017-0447-x · Cited by 97
Peptide-siRNA nanocomplexes targeting NF-κB subunit p65 suppress nascent experimental arthritis
Zhou, H.-F., Yan, H., Pan, H., Hou, K. K., Akk, A. M., Springer, L. E., Hu, Y., Allen, J. S., Wickline, S. A., & Pham, C. T. N. (2014) · Journal of Clinical Investigation · doi:10.1172/jci75673 · Cited by 96
Möller, B., Kollert, F., Sculean, A., & Villiger, P. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01108 · Cited by 96
Delivery of rapamycin by PLGA nanoparticles enhances its suppressive activity on dendritic cells
Haddadi, A., Elamanchili, P., Lavasanifar, A., Das, S., Shapiro, J., & Samuel, J. (2007) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.31373 · Cited by 94
Engineering better chimeric antigen receptor T cells
Zhang, H., Zhao, P., & Huang, H. (2020) · Experimental Hematology & Oncology · doi:10.1186/s40164-020-00190-2 · Cited by 93
Allogeneic hematopoietic SCT for patients with autoimmune diseases
Daikeler, T. D., Hügle, T., Farge, D., Andolina, M., Gualandi, F., Baldomero, H., Bocelli‐Tyndall, C., Brune, M. L., Dalle, J., Ehninger, G., et al. (2009) · Bone Marrow Transplantation · doi:10.1038/bmt.2008.424 · Cited by 92
Holmøy, T., Kvale, E. Ø., & Vartdal, F. (2004) · Journal of NeuroVirology · doi:10.1080/13550280490499524 · Cited by 92
Kuo, R., Saito, E., Miller, S. D., & Shea, L. D. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.03.032 · Cited by 92
Transdermal immunomodulation: Principles, advances and perspectives
Zhao, Z., Ukidve, A., Dasgupta, A., & Mitragotri, S. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.03.010 · Cited by 92
Bispecific Antibodies for Autoimmune and Inflammatory Diseases: Clinical Progress to Date
Zhao, Q. (2020) · BioDrugs · doi:10.1007/s40259-019-00400-2 · Cited by 92
Lobell, A., Weissert, R., Storch, M. K., Svanholm, C., de Graaf, K. L., Lassmann, H., Andersson, R., Olsson, T. P., & Wigzell, H. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.9.1543 · Cited by 91
Long-term Clinical Outcomes of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis
Boffa, G., Massacesi, L., Inglese, M., Mariottini, A., Capobianco, M. A. N., Moiola, L., Amato, M. P., Cottone, S., Gualandi, F., Gobbi, M. D., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000011461 · Cited by 91
Glatiramer acetate (Copaxone®) therapy for multiple sclerosis
Dhib-Jalbut, S. S. (2003) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(03)00036-6 · Cited by 90
Immune regulation of multiple sclerosis by transdermally applied myelin peptides
Juryńczyk, M., Walczak, A., Jurewicz, A., Jesionek‐Kupnicka, D., Szczepanik, M., & Selmaj, K. W. (2010) · Annals of Neurology · doi:10.1002/ana.22219 · Cited by 90
Gold Nanoparticles: Multifaceted Roles in the Management of Autoimmune Disorders
Koushki, K., Shahbaz, S. K., Keshavarz, M., Bezsonov, E. E., Sathyapalan, T., & Sahebkar, A. (2021) · Biomolecules · doi:10.3390/biom11091289 · Cited by 90
Patterns of systemic lupus erythematosus expression in Europe
Cervera, R., Doria, A., Amoura, Z., Khamashta, M. A., Schneider, M., Guillemin, F., Maurel, F., Garofano, A., Roset, M., Perna, A., et al. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.11.007 · Cited by 89
Lewis, J. S., Stewart, J. M., Marshall, G. P., Carstens, M. R., Zhang, Y., Dolgova, N. V., Xia, C., Brusko, T. M., Wasserfall, C. H., Clare-Salzler, M. J., et al. (2019) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.9b00332 · Cited by 89
Vandenbark, A. A., Rich, C. M., Mooney, J., Zamora, A., Wang, C., Huan, J., Fugger, L. H., Offner, H., Jones, R. E., & Burrows, G. G. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.1.127 · Cited by 88
Cho, J. J., Stewart, J. M., Drashansky, T. T., Brusko, M., Zuniga, A. N., Lorentsen, K. J., Keselowsky, B. G., & Avram, D. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.07.029 · Cited by 86
Preclinical development and first-in-human study of ATX-MS-1467 for immunotherapy of MS
Streeter, H. B., Rigden, R., Martin, K. F., Scolding, N. J., & Wraith, D. C. (2015) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000093 · Cited by 84
The role of PTPN22 in the pathogenesis of autoimmune diseases: A comprehensive review
Tizaoui, K., Terrazzino, S., Cargnin, S., Lee, K. H., Gauckler, P., Li, H. J., Shin, J. I., & Kronbichler, A. (2021) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2021.03.004 · Cited by 84
Karlson, E. W., Chibnik, L. B., Cui, J., Plenge, R. M., Glass, R. J., Maher, N. E., Parker, A. N., Roubenoff, R., Izmailova, E. S., Coblyn, J. S., et al. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.071662 · Cited by 83
Engineering Immune Tolerance with Biomaterials
Gammon, J. M., & Jewell, C. M. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201801419 · Cited by 83
7T MRI Differentiates Remyelinated from Demyelinated Multiple Sclerosis Lesions
Kolb, H., Absinta, M., Beck, E., Ha, S.-K., Song, Y., Norato, G., Cortese, I. C. M., Sati, P., Nair, G., & Reich, D. S. (2021) · Annals of Neurology · doi:10.1002/ana.26194 · Cited by 83
Self-citationMasteller, E. L., Warner, M. R., Ferlin, W. G., Judkowski, V. A., Wilson, D. B., Glaichenhaus, N., & Bluestone, J. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.10.5587 · Cited by 82
Blau, R., Krivitsky, A., Epshtein, Y., & Satchi‐Fainaro, R. (2016) · Drug Resistance Updates · doi:10.1016/j.drup.2016.06.003 · Cited by 82
Ogunrinde, E., Zhou, Z., Luo, Z., Alekseyenko, A. V., Li, Q., Macêdo, D. S., Kamen, D. L., Oates, J. C., Gilkeson, G. S., & Jiang, W. (2019) · Arthritis & Rheumatology · doi:10.1002/art.40935 · Cited by 82
Anti-inflammatory, analgesic and anti-tumor properties of gold nanoparticles
Júnior, R. F. D. A., de Araújo, A. A., Pessoa, J. B., Neto, F. P. F., da Silva, G. R., Oliveira, A. L. C. S. L., de Carvalho, T. G., da Silva, H. F. O., Eugênio, M., Sant’Anna, C., et al. (2016) · Pharmacological Reports · doi:10.1016/j.pharep.2016.09.017 · Cited by 81
Casey, L. M., Pearson, R. M., Hughes, K. R., Liu, J. M.-H., Rose, J. A., North, M. G., Wang, L. Z., Lei, M., Miller, S. D., & Shea, L. D. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.7b00624 · Cited by 81
ETS1 governs pathological tissue-remodeling programs in disease-associated fibroblasts
Yan, M., Komatsu, N., Muro, R., Huynh, N. C., Tomofuji, Y., Okada, Y., Suzuki, H. I., Takaba, H., Kitazawa, R., Kitazawa, S., et al. (2022) · Nature Immunology · doi:10.1038/s41590-022-01285-0 · Cited by 81
Bossini‐Castillo, L., Broen, J. C. A., Simeón‐Aznar, C. P., Beretta, L., Vonk, M. C., Ortego‐Centeno, N., Espinosa, G., Carreira, P. E., Camps, M. T., Navarrete‐Navarrete, N., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.141838 · Cited by 80
Büyüktimkin, B., Wang, Q., Kiptoo, P. K., Stewart, J. M., Berkland, C. J., & Siahaan, T. J. (2012) · Molecular Pharmaceutics · doi:10.1021/mp200614q · Cited by 79
Shi, Q., Rondon-Cavanzo, E.-P., Picola, I. P. D., Tiera, M. J., Zhang, X., Dai, K., Benabdoune, H., Benderdour, M., & Fernandes, J. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s146942 · Cited by 77
Intestinal Dysbiosis and Tryptophan Metabolism in Autoimmunity
Brown, J., Robusto, B. A., & Morel, L. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01741 · Cited by 77
Peine, K. J., Guerau‐de‐Arellano, M., Lee, P. M. Y., Kanthamneni, N., Severin, M. E., Probst, G. D., Peng, H., Yang, Y., VanGundy, Z., Papenfuss, T. L., et al. (2014) · Molecular Pharmaceutics · doi:10.1021/mp4005172 · Cited by 76
The mRNA Vaccine Revolution: COVID-19 Has Launched the Future of Vaccinology
Ye, Z., Harmon, J., Ni, W., Li, Y., Wich, D., & Xu, Q. (2023) · ACS Nano · doi:10.1021/acsnano.2c12584 · Cited by 75
Positron emission tomography in multiple sclerosis - straight to the target
Bodini, B., Tonietto, M., Airas, L., & Stankoff, B. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-021-00537-1 · Cited by 74
Akbarpour, M., Goudy, K., Cantore, A., Russo, F., Sanvito, F., Naldini, L., Annoni, A., & Roncarolo, M. G. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa3032 · Cited by 74
Subcutaneous Abatacept in Patients With Polyarticular‐Course Juvenile Idiopathic Arthritis
Brunner, H. I., Tzaribachev, N., Vega‐Cornejo, G., Louw, I., Berman, A., Penadés, I. C., Antón, J., Ávila‐Zapata, F., Cuttica, R. J., Horneff, G., et al. (2018) · Arthritis & Rheumatology · doi:10.1002/art.40466 · Cited by 73
Advances in Understanding of Pathogenesis and Treatment of Immune-Mediated Kidney Disease: A Review
Kant, S., Kronbichler, A., Sharma, P., & Geetha, D. (2021) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2021.07.019 · Cited by 73
Rossi, E. A., Goldenberg, D. M., Cardillo, T. M., Stein, R., & Chang, C. (2009) · Blood · doi:10.1182/blood-2008-10-187138 · Cited by 72
Galea, R. C., Nel, H. J., Talekar, M., Liu, X., Ooi, J. D., Huynh, M., Hadjigol, S., Robson, K. J., Ting, Y. T., Cole, S., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.126025 · Cited by 72
Ford, J. A., Liu, X., Chu, S. H., Lü, B., Cho, M. H., Silverman, E. K., Costenbader, K. H., Camargo, C. A., & Sparks, J. A. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41194 · Cited by 72
Wilson, D. S., Damo, M., Hirosue, S., Raczy, M. M., Brünggel, K., Diaceri, G., Quaglia-Thermes, X., & Hubbell, J. A. (2019) · Nature Biomedical Engineering · doi:10.1038/s41551-019-0424-1 · Cited by 71
Yin, N., Tan, X., Liu, H., He, F., Ding, N., Gou, J., Yin, T., He, H., Zhang, Y. X., & Tang, X. (2020) · Nanoscale · doi:10.1039/d0nr00454e · Cited by 71
Kalinčík, T., Sharmin, S., Roos, I., Freedman, M. S., Atkins, H. L., Burman, J., Massey, J. C., Sutton, I., Withers, B., Macdonell, R. A. L., et al. (2023) · JAMA Neurology · doi:10.1001/jamaneurol.2023.1184 · Cited by 71
Perugino, C. A., Wallace, Z. S., Zack, D. J., et al. (2023) · The Lancet Rheumatology · doi:10.1016/s2665-9913(23)00157-1 · Cited by 71
Pasquini, M. C., Voltarelli, J. C., Atkins, H. L., Hamerschlak, N., Zhong, X., Ahn, K. W., Sullivan, K. M., Carrum, G., Andrey, J., Bredeson, C., et al. (2012) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2012.06.003 · Cited by 70
The effects of PDL-Ig on collagen-induced arthritis
Wang, G., Hu, P., Yang, J. L., Shen, G., & Wu, X. (2009) · Rheumatology International · doi:10.1007/s00296-009-1249-0 · Cited by 68
Jansen, M. A. A., Klausen, L. H., Thanki, K., Lyngsø, J., Pedersen, J. S., Franzyk, H., Nielsen, H. M., van Eden, W., Dong, M., Broere, F., et al. (2019) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2019.06.009 · Cited by 68
Paving the way towards an effective treatment for multiple sclerosis: advances in cell therapy
Mansilla, M. J., Presas‐Rodríguez, S., Teniente‐Serra, A., González-Larreategui, Í., Quirant‐Sánchez, B., Fondelli, F., Djedović, N., Iwaszkiewicz‐Grześ, D., Chwojnicki, K., Miljković, D. M., et al. (2021) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-00618-z · Cited by 68
Merrill, J. T., Guthridge, J. M., Smith, M. C., June, J., Koumpouras, F., Machua, W., Askanase, A., Khosroshahi, A., Sheikh, S. Z., Rathi, G., et al. (2023) · Arthritis & Rheumatology · doi:10.1002/art.42652 · Cited by 68
Tatović, D., McAteer, M. A., Barry, J., Barrientos, Á. G., Terradillos, K. R., Perera, I., Kochba, E., Levin, Y., Dul, M., Coulman, S. A., et al. (2022) · Immunotherapy Advances · doi:10.1093/immadv/ltac002 · Cited by 66
Immunotherapeutic nanoparticles: From autoimmune disease control to the development of vaccines
Mitarotonda, R., Giorgi, E. D., Eufrásio-da-Silva, T., Dolatshahi‐Pirouz, A., Mishra, Y. K., Khademhosseini, A., Desimone, M. F., Marzi, M. C. D., & Orive, G. (2022) · Biomaterials Advances · doi:10.1016/j.bioadv.2022.212726 · Cited by 65
World Bispecific Antibody Summit, September 27–28, 2011, Boston, MA
Dhimolea, E., & Reichert, J. M. (2012) · mAbs · doi:10.4161/mabs.4.1.18821 · Cited by 64
Tsunoda, I., Kuang, L., Tolley, N. D., Whitton, J. L., & Fujinami, R. S. (1998) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199808000-00005 · Cited by 63
Hippisley-Cox, J., & Coupland, C. (2015) · BMJ · doi:10.1136/bmj.h5441 · Cited by 63
Lactococcus lactis As a Versatile Vehicle for Tolerogenic Immunotherapy
Cook, D. P., Gysemans, C. A., & Mathieu, C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01961 · Cited by 63
Bue‐Valleskey, J. M., KAZDA, C. M., Ma, C., Chien, J. Y., Zhang, Q., Chigutsa, E., Landschulz, W. H., Haupt, A., & Frías, J. P. (2023) · Diabetes Care · doi:10.2337/dc22-2396 · Cited by 63
Tremain, A. C., Wallace, R. P., Lorentz, K. M., Thornley, T. B., Antane, J. T., Raczy, M. M., Reda, J. W., Alpar, A. T., Slezak, A. J., Watkins, E. A., et al. (2023) · Nature Biomedical Engineering · doi:10.1038/s41551-023-01086-2 · Cited by 63
Kavanagh, D. G., Kaufmann, D., Sunderji, S., Frahm, N., Gall, S. L., Boczkowski, D., Rosenberg, E. S., Stone, D. R., Johnston, M. N., Wagner, B. S., et al. (2005) · Blood · doi:10.1182/blood-2005-04-1513 · Cited by 62
Glatt, S., Taylor, P. C., McInnes, I. B., Schett, G. A., Landewé, R., Baeten, D., Ionescu, L., Strimenopoulou, F., Watling, M. I. L., & Shaw, S. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2018-214943 · Cited by 62
Orvain, C., Boulch, M., Bousso, P., Allanore, Y., & Avouac, J. (2021) · Arthritis & Rheumatology · doi:10.1002/art.41812 · Cited by 62
Murray, J. A., Wassaf, D., Dunn, K., Arora, S., Winkle, P. J., Stacey, H. L., Cooper, S., Goldstein, K. E., Manchanda, R., Kontos, S., et al. (2023) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(23)00107-3 · Cited by 62
Aranow, C. B., Allaart, C. F., Amoura, Z., Bruce, I. N., Cagnoli, P. C., Chatham, W. W., Clark, K. L., Furie, R. A., Groark, J., Urowitz, M. B., et al. (2024) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2024-225686 · Cited by 62
Multiple sclerosis: autoimmunity and viruses
Cusick, M. F., Libbey, J. E., & Fujinami, R. S. (2013) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e328362004d · Cited by 61
Chu, S. Y., Yeter, K. C., Kotha, R., Pong, E., Miranda, Y., Phung, S., Chen, H., Lee, S., Leung, I., Bonzon, C., et al. (2013) · Arthritis & Rheumatology · doi:10.1002/art.38334 · Cited by 61
Fishman, S., Lewis, M. D., Siew, L. K., Leenheer, E. D., Kakabadse, D., Davies, J. E., Ziv, D., Margalit, A., Karin, N., Gross, G., et al. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2016.12.007 · Cited by 61
Passeri, L., Andolfi, G., Bassi, V., Russo, F., Giacomini, G., Laudisa, C., Marrocco, I., Cesana, L., Stefano, M. D., Fanti, L., et al. (2023) · Journal of Autoimmunity · doi:10.1016/j.jaut.2023.103051 · Cited by 61
Ruiz, P. J., Garren, H., Hirschberg, D. L., Langer-Gould, A. M., Levite, M., Karpuj, M. V., Southwood, S., Sette, A., Conlon, P. J., & Steinman, L. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.8.1275 · Cited by 60
Bolstad, A. I., Hellard, S. L., Kristjansdottir, G., Vasaitis, L., Kvarnström, M., Sjöwall, C., Johnsen, S. J. A., Eriksson, P., Omdal, R., Brun, J. G., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200446 · Cited by 60
Dul, M., Nikolić, T., Stefanidou, M., McAteer, M. A., Williams, P. M., Mous, J., Roep, B. O., Kochba, E., Levin, Y., Peakman, M., et al. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.03.041 · Cited by 60
Lacy, S. E., Wu, C., Ambrosi, D. J., Hsieh, C.-M., Bose, S., Miller, R., Conlon, D., Tarcsa, E., Chari, R. V. J., Ghayur, T., et al. (2015) · mAbs · doi:10.1080/19420862.2015.1026501 · Cited by 58
Li, C., Chen, X., Luo, X., Wang, H., Zhu, Y., Du, G., Chen, W., Chen, Z., Hao, X., Zhang, Z., et al. (2021) · Nano Letters · doi:10.1021/acs.nanolett.0c05110 · Cited by 58
Regulatory CAR-T cells in autoimmune diseases: Progress and current challenges
Riët, T., & Chmielewski, M. M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.934343 · Cited by 58
Gene therapy for autoimmune diseases: quo vadis?
Chernajovsky, Y., Gould, D., & Podhajcer, O. L. (2004) · Nature reviews. Immunology · doi:10.1038/nri1459 · Cited by 57
Trans-Ancestral Studies Fine Map the SLE-Susceptibility Locus TNFSF4
Manku, H., Langefeld, C. D., Guerra, S. G., Malik, T. H., Alarcón-Riquelme, M. E., Anaya, J., Bae, S., Boackle, S. A., Brown, E. E., Criswell, L. A., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003554 · Cited by 57
Benschop, R. J., Chow, C.-K., Tian, Y., Nelson, J., Barmettler, B., Atwell, S., Clawson, D. K., Chai, Q., Jones, B. E., Fitchett, J. R., et al. (2019) · mAbs · doi:10.1080/19420862.2019.1624463 · Cited by 57
Nanoparticles for Inducing Antigen-Specific T Cell Tolerance in Autoimmune Diseases
Benne, N., ter Braake, D., Stoppelenburg, A. J., & Broere, F. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.864403 · Cited by 57
Kazda, C. M., Bue-Valleskey, J. M., Chien, J., Zhang, Q., Chigutsa, E., Landschulz, W., Wullenweber, P., Haupt, A., & Dahl, D. (2023) · Diabetes Care · doi:10.2337/dc22-2395 · Cited by 56
Rigid-body Ligand Recognition Drives Cytotoxic T-lymphocyte Antigen 4 (CTLA-4) Receptor Triggering
Yu, C., Sonnen, A. F. ‐., George, R., Dessailly, B. H., Stagg, L., Evans, E. J., Orengo, C. A., Stuart, D. I., Ladbury, J. E., Ikemizu, S., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.182394 · Cited by 56
Stohl, W., Gómez-Reino, J. J., Olech, E., Dudler, J., Fleischmann, R., Zerbini, C. A. F., Ashrafzadeh, A., Grzeschik, S. M., Bieraugel, R., Green, J., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200706 · Cited by 56
Lai, C., Lai, W., Chiou, M., Lin, W., Yang, Y.-J., Li, C., & Tsai, L.-M. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-207719 · Cited by 55
Kubara, K., Yamazaki, K., Miyazaki, T., Kondo, K., Kurotaki, D., Tamura, T., & Suzuki, Y. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.01.020 · Cited by 55
A revolutionary therapeutic approach for psoriasis: bispecific biological agents
Torres, T., Romanelli, M., & Chiricozzi, A. (2016) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2016.1187130 · Cited by 54
Zhukovsky, C., Sandgren, S., Silfverberg, T., Einarsdottir, S., Tolf, A., Landtblom, A., Novakova, L., Axelsson, M., Malmeström, C., Cherif, H., et al. (2020) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2020-323992 · Cited by 54
Oliver, R., Krueger, J. G., Glatt, S., Vajjah, P., Mistry, C., Page, M., Edwards, H., Garcet, S., Li, X., Dizier, B., et al. (2021) · British Journal of Dermatology · doi:10.1111/bjd.20827 · Cited by 54
Whittington, K. B., Prislovsky, A., Beaty, J., Albritton, L. M., Radic, M. Z., & Rosloniec, E. F. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2100643 · Cited by 54
A T follicular helper cell origin for T regulatory type 1 cells
Solé, P., Yamanouchi, J., Garnica, J., Uddin, M. M., Clarke, R. C., Moro, J., Garabatos, N., Thiessen, S., Ortega, M., Singha, S., et al. (2023) · Cellular and Molecular Immunology · doi:10.1038/s41423-023-00989-z · Cited by 54
Mäkelä, M., Vaarala, O., Hermann, R., Salminen, K., Vahlberg, T. J., Veijola, R., Hyöty, H., Knip, M., Simell, O., & Ilonen, J. (2006) · Journal of Autoimmunity · doi:10.1016/j.jaut.2006.04.003 · Cited by 53
Kim, S., Moon, J.-H., Jeong, S.-U., Jung, H.-H., Park, C., Hwang, B. Y., & Lee, C. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s210546 · Cited by 53
Firdessa-Fite, R., & Creusot, R. J. (2019) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2019.10.015 · Cited by 53
Autoimmune manifestations in aged mice arise from early-life immune dysregulation
Mahmoud, T. I., Wang, J., Karnell, J. L., Wang, Q., Wang, S., Naiman, B. M., Gross, P. S., Brohawn, P. Z., Morehouse, C., Aoyama, J., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aag0367 · Cited by 52
Biotherapeutics: Challenges and Opportunities for Predictive Toxicology of Monoclonal Antibodies
Johnson, D. E. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113685 · Cited by 52
Bispecific antibodies: The next generation of targeted inflammatory bowel disease therapies
Peyrin‐Biroulet, L., Demarest, S. J., & Nirula, A. (2018) · Autoimmunity Reviews · doi:10.1016/j.autrev.2018.07.014 · Cited by 52
Nanoparticle-siRNA: A potential strategy for rheumatoid arthritis therapy?
Feng, N., & Guo, F. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.07.006 · Cited by 52
Levit, R., Cortes‐Perez, N. G., de LeBlanc, A. D. M., Loiseau, J., Aucouturier, A., Langella, P., LeBlanc, J. G., & Bermúdez‐Humarán, L. G. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2110821 · Cited by 52
Su, L. F., del Alcazar, D., Stelekati, E., Wherry, E. J., & Davis, M. M. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1611723113 · Cited by 51
Braley‐Mullen, H., Tompson, J. G., Sharp, G. C., & Kyriakos, M. (1980) · Cellular Immunology · doi:10.1016/0008-8749(80)90272-5 · Cited by 51
Suppression of Chronic Allergic Encephalomyelitis: Relevance to Multiple Sclerosis
Raine, C. S., Traugott, U., & Stone, S. H. (1978) · Science · doi:10.1126/science.78524 · Cited by 49
Exploring the role of polymers to overcome ongoing challenges in the field of extracellular vesicles
Simon, L., Lapinte, V., & Morille, M. (2023) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12386 · Cited by 49
Microneedle delivery of autoantigen for immunotherapy in type 1 diabetes
Zhao, X. Y., Birchall, J. C., Coulman, S. A., Tatović, D., Singh, R., Li, W., Wong, F. S., Dayan, C. M., & Hanna, S. J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.12.040 · Cited by 48
Pei, W., Wan, X., Shahzad, K. A., Zhang, L., Song, S., Jin, X., Wang, L., Zhao, C., & Shen, C. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s164500 · Cited by 48
Brzezicka, K., Arlian, B. M., Wang, S., Olmer, M., Lotz, M., & Paulson, J. C. (2022) · ACS Nano · doi:10.1021/acsnano.2c05643 · Cited by 48
Zhang, B., Sun, J., Yuan, Y., Ji, D., Sun, Y., Liu, Y., Li, S., Zhu, X., Wu, X., Hu, J., et al. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01208-3 · Cited by 48
Szili, D., Cserhalmi, M., Bankó, Z., Nagy, G., Szymkowski, D. E., & Sármay, G. (2014) · mAbs · doi:10.4161/mabs.28841 · Cited by 46
Induction and Suppression of an Autoimmune Disease by Oligomerized T Cell Epitopes
Falk, K., Rötzschke, O., Santambrogio, L., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.4.717 · Cited by 46
Cigarette smoking and the risk of primary Sjögren’s syndrome: a nested case control study
Olsson, P., Turesson, C., Mandl, T., Jacobsson, L., & Theander, E. (2017) · Arthritis Research & Therapy · doi:10.1186/s13075-017-1255-7 · Cited by 46
Nanoparticle-delivered siRNA targeting Bruton's tyrosine kinase for rheumatoid arthritis therapy
Zhao, G., Liu, A., Zhang, Y., Zuo, Z.-Q., Cao, Z., Zhang, H., Xu, C., & Wang, J. (2019) · Biomaterials Science · doi:10.1039/c9bm01025d · Cited by 46
Luo, Y., Liang, L., Gan, Y.-J., Liu, J., Zhang, Y., Fan, Y.-N., Zhao, G., Czarna, A., Lu, Z.-D., Du, X., et al. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c10885 · Cited by 46
Lactic Acid Bacteria for Delivery of Endogenous or Engineered Therapeutic Molecules
Bron, P. A., & Kleerebezem, M. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01821 · Cited by 45
Boffa, G., Signori, A., Massacesi, L., Mariottini, A., Sbragia, E., Cottone, S., Amato, M. P., Gasperini, C., Moiola, L., Meletti, S., et al. (2022) · Neurology · doi:10.1212/wnl.0000000000206750 · Cited by 45
Gene Therapy for Autoimmune Disease
Shu, S.-A., Wang, J., Tao, M., & Leung, P. S. C. (2014) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-014-8451-x · Cited by 44
Vacchio, M. S., Ciucci, T., Gao, Y., Watanabe, M., Balmaceno-Criss, M., McGinty, M. T., Huang, A., Xiao, Q., McConkey, C., Zhao, Y., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.06.023 · Cited by 44
Nitric oxide and the axonal death cascade
Waxman, S. G. (2003) · Annals of Neurology · doi:10.1002/ana.10397 · Cited by 43
Thorlacius, G. E., Hultin‐Rosenberg, L., Sandling, J. K., Bianchi, M., Imgenberg‐Kreuz, J., Pucholt, P., Theander, E., Kvarnström, M., Forsblad‐d’Elia, H., Bucher, S. M., et al. (2020) · Rheumatology · doi:10.1093/rheumatology/keaa367 · Cited by 43
Yadav, V., BOURDETTE, D. N., Bowen, J. D., LYNCH, S. G., Mattson, D. H., Preiningerova, J. L., Bever, C. T., Simon, J. H., Goldstein, A., Burrows, G. G., et al. (2012) · Autoimmune Diseases · doi:10.1155/2012/954739 · Cited by 42
Functional Ambivalence of Dendritic Cells: Tolerogenicity and Immunogenicity
Nam, J.-H., Lee, J., Choi, S.-Y., Jung, N.-C., Song, J. Y., Seo, H. G., & Lim, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094430 · Cited by 42
Tolerogenic Nanovaccine for Prevention and Treatment of Autoimmune Encephalomyelitis
Park, J.-W., Le, Q., Wu, Y., Lee, J., & Oh, Y. (2022) · Advanced Materials · doi:10.1002/adma.202202670 · Cited by 42
Self-citationCarretero-Iglesia, L., Bouchet‐Delbos, L., Louvet, C., Drujont, L., Segovia, M., Mérieau, E., Chiffoleau, E., Josien, R., Hill, M., Cuturi, M. C., et al. (2016) · Transplantation · doi:10.1097/tp.0000000000001315 · Cited by 41
Belogurov, A. A., Анатольевич, З. К., Lomakin, Y. A., Surkov, K. G., Avtushenko, S., Kruglyakov, P. V., Smirnov, I. V., Makshakov, G., Lockshin, C., Gregoriadis, G., et al. (2016) · Neurotherapeutics · doi:10.1007/s13311-016-0448-0 · Cited by 40
Recent Advances in Antigen-Specific Immunotherapies for the Treatment of Multiple Sclerosis
Kammona, O., & Kiparissides, C. A. (2020) · Brain Sciences · doi:10.3390/brainsci10060333 · Cited by 40
Epigenetic Regulation of Nutrient Transporters in Rheumatoid Arthritis Fibroblast‐like Synoviocytes
Torres, A., Pedersen, B., Cobo, I., Ai, R., Coras, R., Murillo‐Saich, J., Nygaard, G., Sánchez‐López, E., Murphy, A. N., Wang, W., et al. (2022) · Arthritis & Rheumatology · doi:10.1002/art.42077 · Cited by 40
Biomaterial-based delivery platforms for transdermal immunotherapy
Dahri, M., Beheshtizadeh, N., Seyedpour, N., Nakhostin-Ansari, A., Aghajani, F., Seyedpour, S., Masjedi, M., Farjadian, F., Maleki, R., & Adibkia, K. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115048 · Cited by 40
Derdelinckx, J., Mansilla, M. J., Laere, M. D., Lee, W.-P., Navarro‐Barriuso, J., Wens, I., Nkansah, I., Daans, J., Reu, H. D., Keliris, A., et al. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1541-1 · Cited by 39
Gupta, P., Goldenberg, D. M., Rossi, E. A., & Chang, C. (2010) · Blood · doi:10.1182/blood-2010-03-276857 · Cited by 38
Towards prevention of autoimmune diseases: The example of rheumatoid arthritis
Hensvold, A. H., & Klareskog, L. (2021) · European Journal of Immunology · doi:10.1002/eji.202048952 · Cited by 38
B-Cell Reconstitution After Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis
von Niederhäusern, V., Ruder, J., Ghraichy, M., Jelčić, I., Müller, A. M. S., Schanz, U., Martinꝉ, R., & Trück, J. (2022) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000200027 · Cited by 38
Wegmann, K. W., Wagner, C. R., Whitham, R. H., & Hinrichs, D. J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.5.3301 · Cited by 37
Anti-CD22/CD20 Bispecific Antibody with Enhanced Trogocytosis for Treatment of Lupus
Rossi, E. A., Chang, C., & Goldenberg, D. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098315 · Cited by 37
Das, S., Haddadi, A., Veniamin, S., & Samuel, J. (2007) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.31557 · Cited by 37
Rhodes, K. R., Tzeng, S. Y., Iglesias, M., Lee, D., Storm, K., Neshat, S. Y., VanDyke, D., Lowmaster, S. M., Spangler, J. B., Raimondi, G., et al. (2023) · Science Advances · doi:10.1126/sciadv.add8693 · Cited by 37
Becker, M. W., Peters, L. D., Myint, T. S., Smurlick, D., Powell, A., Brusko, T. M., & Phelps, E. A. (2023) · Science Advances · doi:10.1126/sciadv.adg1082 · Cited by 37
A new MHC-linked susceptibility locus for primary Sjögren’s syndrome: MICA
Carapito, R., Gottenberg, J., Kotova, I., Untrau, M., Michel, S., Naegely, L., Aouadi, I., Kwemou, M., Paul, N., Pichot, A., et al. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx135 · Cited by 36
Hartwell, B. L., Pickens, C. J., Leon, M. A., Northrup, L., Christopher, M. A., Griffin, J. D., Martinez-Becerra, F. J., & Berkland, C. J. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.06.006 · Cited by 36
Malviya, M., Saoudi, A., Bauer, J., Fillatreau, S., & Liblau, R. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102401 · Cited by 36
Lyman, M. A., Lieuw, V., Richardson, R., Timmer, A. M., Stewart, C., Granger, S. W., Woods, R., Silacci, M., Grabulovski, D., & Newman, R. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.818559 · Cited by 35
Arikat, F., Hanna, S. J., Singh, R., Vilela, L., Wong, F. S., Dayan, C. M., Coulman, S. A., & Birchall, J. C. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.02.031 · Cited by 35
Restimulation‐induced cell death: new medical and research perspectives
Zheng, L., Li, J., & Lenardo, M. J. (2017) · Immunological Reviews · doi:10.1111/imr.12535 · Cited by 34
Self-citationChen, X., Du, G., Bai, S., Dijia, L., Li, C., Hou, Y., Zhang, Y., Zhang, Z., Gong, T., Fu, Y. S., et al. (2021) · Nano Today · doi:10.1016/j.nantod.2021.101307 · Cited by 34
Biomaterial Strategies for Selective Immune Tolerance: Advances and Gaps
Carey, S. T., Bridgeman, C. J., & Jewell, C. M. (2023) · Advanced Science · doi:10.1002/advs.202205105 · Cited by 34
Lomakin, Y. A., Belogurov, A. A., Глаголева, И. С., Stepanov, A. V., Анатольевич, З. К., Okunola, J., Smirnov, I. V., Genkin, D. D., & Gabibov, A. G. (2016) · Mediators of Inflammation · doi:10.1155/2016/2847232 · Cited by 33
Hartwell, B. L., Pickens, C. J., Leon, M. A., & Berkland, C. J. (2017) · Biomacromolecules · doi:10.1021/acs.biomac.7b00335 · Cited by 33
Engineered T cells and their therapeutic applications in autoimmune diseases
Bao, L., 上海交通大学医学院上海市免疫学研究所免疫学和微生物学系, 上., Bo, X., Cao, H.-W., Qian, C., Wang, Z., & Li, B. (2022) · 动物学研究 · doi:10.24272/j.issn.2095-8137.2021.363 · Cited by 33
Suppression of Ongoing T Cell-Mediated Autoimmunity by Peptide-MHC Class II Dimer Vaccination
Li, L., Yi, Z., Wang, B., & Tisch, R. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901616 · Cited by 32
Common variants near IKZF1 are associated with primary Sjögren's syndrome in Han Chinese
Qu, S., Du, Y., Chang, S., Guo, L., Fang, K., Li, Y., Zhang, F., Zhang, K., & Wang, J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177320 · Cited by 32
Quirant‐Sánchez, B., Mansilla, M. J., Navarro‐Barriuso, J., Presas‐Rodríguez, S., Teniente‐Serra, A., Fondelli, F., Ramo-Tello, C. M., & Martínez-Cáceres, E. M. (2021) · Biomedicines · doi:10.3390/biomedicines9121758 · Cited by 32
Silfverberg, T., Zjukovskaja, C., Ljungman, P. T., Nahimi, A., Ahlstrand, E., Dreimane, A., Einarsdottir, S., Fagius, J., Iacobaeus, E., Hägglund, H., et al. (2023) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2023-331864 · Cited by 32
Cook, D. P., da Cunha, J. P. M. C. M., Martens, P.-J., Sassi, G., Mancarella, F., Ventriglia, G., Sebastiani, G., Vanherwegen, A.-S., Atkinson, M. A., Huynegem, K. V., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01103 · Cited by 31
Erythrocyte-enabled immunomodulation for vaccine delivery
Wang, F., Zong, R., & Chen, G. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.11.035 · Cited by 31
Novel therapeutic strategies for autoimmune and inflammatory rheumatic diseases
Felten, R., Mertz, P., Sebbag, E., Scherlinger, M., & Arnaud, L. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103612 · Cited by 31
Gomi, M., Nakayama, Y., Sakurai, Y., Oyama, R., Iwasaki, K., Doi, M., Liu, Y., Hori, M., Watanabe, H., Hashimoto, K., et al. (2023) · Pharmaceuticals · doi:10.3390/ph16091270 · Cited by 31
Eras of designer Tregs: Harnessing synthetic biology for immune suppression
Tuomela, K., Salim, K., & Levings, M. K. (2023) · Immunological Reviews · doi:10.1111/imr.13254 · Cited by 30
Zhao, Y., Chen, X., He, P., Wang, X., Xu, Y., Hu, R. M., Ou, Y., Zhang, Z., Zhang, Z., Du, G., et al. (2023) · Small · doi:10.1002/smll.202307366 · Cited by 30
The use of basic proteins to increase the infectivity of enterovirus ribonucleic acid
Smull, C. E., Mallette, M. F., & LUDWIG, E. H. (1961) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(61)90155-3 · Cited by 29
Herman, S., Fischer, A., Présumey, J., Hoffmann, M. H., Koenders, M. I., Escriou, V., Apparailly, F., & Steiner, G. E. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39223 · Cited by 29
Rampelbergh, J. V., Achenbach, P., Leslie, R. D., Ali, M. A., Dayan, C. M., Keymeulen, B., Owen, K. R., Kindermans, M., Parmentier, F., Carlier, V. A., et al. (2023) · BMC Medicine · doi:10.1186/s12916-023-02900-z · Cited by 29
Margot, C. D., Ford, M. L., & Evavold, B. D. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.6.3352 · Cited by 27
Geluk, A., van Meijgaarden, K. E., Roep, B. O., & Ottenhoff, T. H. M. (1998) · Journal of Autoimmunity · doi:10.1006/jaut.1998.0207 · Cited by 27
Zeher, M., Papp, G., Nakken, B., & Szodoray, P. (2017) · Autoimmunity Reviews · doi:10.1016/j.autrev.2017.05.020 · Cited by 27
Hong, J., Xiao, X., Gao, Q., Li, S., Jiang, B., Sun, X., Ran, P., & Yang, P. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s215415 · Cited by 27
30 Years of Biotherapeutics Development—What Have We Learned?
Ghilardi, N., Pappu, R., Arron, J. R., & Chan, A. C. (2020) · Annual Review of Immunology · doi:10.1146/annurev-immunol-101619-031510 · Cited by 27
Ruder, J., Docampo, M. J., Rex, J., Obahor, S., Naghavian, R., Müller, A. M. S., Schanz, U., Jelčić, I., & Martinꝉ, R. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abq1693 · Cited by 27
Cell and biomaterial delivery strategies to induce immune tolerance
Scotland, B. L., Shaw, J. R., Dharmaraj, S., Caprio, N., Cottingham, A. L., Lasola, J. J., Sung, J. J., & Pearson, R. M. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115141 · Cited by 27
Ayoglu, B., Donato, M., Furst, D. E., Crofford, L. J., Goldmuntz, E. A., Keyes-Elstein, L., James, J. A., Macwana, S., Mayes, M. D., McSweeney, P. A., et al. (2023) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2021-221926 · Cited by 26
Stienekemeier, M., Falk, K., Rötzschke, O., Weishaupt, A., Schneider‐Gold, C., Toyka, K. V., Gold, R., & Strominger, J. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241504598 · Cited by 25
Song, J., Chen, Y., Jiang, S., Yang, K., Li, X., Zhao, X., Ouyang, Y., Fan, C., & Yuan, W. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00305 · Cited by 25
Persistent antigen exposure via the eryptotic pathway drives terminal T cell dysfunction
Watkins, E. A., Antane, J. T., Roberts, J., Lorentz, K. M., Zuerndorfer, S., Dunaif, A., Bailey, L. J., Tremain, A. C., Nguyen, M., Loera, R. D., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abe1801 · Cited by 25
Rossi, E. A., Chang, C., Cardillo, T. M., & Goldenberg, D. M. (2012) · Bioconjugate Chemistry · doi:10.1021/bc300488f · Cited by 24
Postigo, J., & Creusot, R. J. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.11.003 · Cited by 24
Kwiatkowski, A. J., Helm, E. Y., Stewart, J. M., Drashansky, T. T., Cho, J. J., Avram, D., & Keselowsky, B. G. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2205417119 · Cited by 23
Metadata
- Authors
- Song, Y., Li, J., & Wu, Y.
- Venue
- Signal Transduction and Targeted Therapy
- Published
- 2024-10-04
- Volume
- 9
- Issue
- 1
- Pages
- 263-263
- ISSN
- 2059-3635 (ISSN-L)
- OpenAlex
- W4403086871
- Cited by
- 259
- References
- 633
- FWCI
- 35.51
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.